A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
| Status: | Completed |
|---|---|
| Conditions: | Healthy Studies |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 4/21/2016 |
| Start Date: | August 2007 |
| End Date: | October 2007 |
This study will evaluate the specificity of the cobas TaqScreen MPX Test for the
simultaneous detection of HBV DNA, HCV RNA and HIV-1 Group M in a minimum of 100,000
individual donor samples in 96-unit pools.
simultaneous detection of HBV DNA, HCV RNA and HIV-1 Group M in a minimum of 100,000
individual donor samples in 96-unit pools.
Inclusion Criteria:
- Healthy adults 18-65 years of age
- Fulfil criteria for plasma donation
Exclusion Criteria:
- Do not fulfil criteria for plasma donation
We found this trial at
3
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials